Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2013, Article ID 789012, 6 pages
http://dx.doi.org/10.1155/2013/789012
Research Article

Gram-Negative Bacterial Lipopolysaccharide Stimulates Activin A Secretion from Human Amniotic Epithelial Cells

1Department of Laboratory Sciences, Graduate School of Health Sciences, Gunma University, 3-39-22 Showa, Maebashi, Gunma 371-8514, Japan
2Kuki General Hospital, Kuki, Saitama 346-0021, Japan
3Miyazaki Prefectural Nobeoka Hospital, Nobeoka, Miyazaki 882-0835, Japan
4Yokota Maternity Hospital, Maebashi, Gunma 371-0031, Japan
5Department of Obstetrics and Gynecology, Graduate School of Medicine, Gunma University, 3-39-22 Showa, Maebashi, Gunma 371-8511, Japan

Received 29 April 2013; Accepted 1 July 2013

Academic Editor: Maria L. Dufau

Copyright © 2013 Yumiko Abe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. de Kretser, R. E. O'Hehir, C. L. Hardy, and M. P. Hedger, “The roles of activin A and its binding protein, follistatin, in inflammation and tissue repair,” Molecular and Cellular Endocrinology, vol. 359, no. 1-2, pp. 101–106, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Werner and C. Alzheimer, “Roles of activin in tissue repair, fibrosis, and inflammatory disease,” Cytokine and Growth Factor Reviews, vol. 17, no. 3, pp. 157–171, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. D. J. Phillips, D. M. de Kretser, and M. P. Hedger, “Activin and related proteins in inflammation: not just interested bystanders,” Cytokine and Growth Factor Reviews, vol. 20, no. 2, pp. 153–164, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Ebert, R. Nau, and U. Michel, “Role of activin in bacterial infections: a potential target for immunointervention?” Immunotherapy, vol. 2, no. 5, pp. 673–684, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Huber and C. Schramm, “Role of activin A in the induction of Foxp3+ and Foxp3− CD4+ regulatory T cells,” Critical Reviews in Immunology, vol. 31, no. 1, pp. 53–60, 2011. View at Google Scholar · View at Scopus
  6. M. P. Hedger, W. R. Winnall, D. J. Phillips, and D. M. de Kretser, “The regulation and functions of activin and follistatin in inflammation and immunity,” Vitamins and Hormones, vol. 85, pp. 255–297, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. K. L. Jones, J. N. Brauman, N. P. Groome, D. M. De Kretser, and D. J. Phillips, “Activin A release into the circulation is an early event in systemic inflammation and precedes the release of follistatin,” Endocrinology, vol. 141, no. 5, pp. 1905–1908, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. K. L. Jones, A. Mansell, S. Patella et al., “Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 41, pp. 16239–16244, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. U. Michel, S. Ebert, D. Phillips, and R. Nau, “Serum concentrations of activin and follistatin are elevated and run in parallel in patients with septicemia,” European Journal of Endocrinology, vol. 148, no. 5, pp. 559–564, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Muttukrishna, P. A. Fowler, L. George, N. P. Groome, and P. G. Knight, “Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy,” Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 9, pp. 3328–3334, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Rabinovici, P. C. Goldsmith, C. L. Librach, and R. B. Jaffe, “Localization and regulation of the activin-A dimer in human placental cells,” Journal of Clinical Endocrinology and Metabolism, vol. 75, no. 2, pp. 571–576, 1992. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Petraglia, M. M. Anceschi, L. Calza et al., “Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release,” Journal of Clinical Endocrinology and Metabolism, vol. 77, no. 2, pp. 542–548, 1993. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Petraglia, A. M. Di Blasio, P. Florio et al., “High levels of fetal membrane activin βA and activin receptor IIB mRNAs and augmented concentration of amniotic fluid activin A in women in term or preterm labor,” Journal of Endocrinology, vol. 154, no. 1, pp. 95–101, 1997. View at Google Scholar · View at Scopus
  14. V. A. Rosenberg, I. A. Buhimschi, A. T. Dulay et al., “Modulation of amniotic fluid activin-a and inhibin-a in women with preterm premature rupture of the membranes and infection-induced preterm birth,” American Journal of Reproductive Immunology, vol. 67, no. 2, pp. 122–131, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. J. A. Keelan, R. L. Zhou, L. W. Evans, N. P. Groome, and M. D. Mitchell, “Regulation of activin A, inhibin A, and follistatin production in human amnion and choriodecidual explants by inflammatory mediators,” Journal of the Society for Gynecologic Investigation, vol. 7, no. 5, pp. 291–296, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. J. A. Keelan, N. P. Groome, and M. D. Mitchell, “Regulation of activin-A production by human amnion, decidua and placenta in vitro by pro-inflammatory cytokines,” Placenta, vol. 19, no. 5-6, pp. 429–434, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. J. A. Keelan, R.-L. Zhou, and M. D. Mitchell, “Activin a exerts both pro- and anti-inflammatory effects on human term gestational tissues,” Placenta, vol. 21, no. 1, pp. 38–43, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. K. M. Adams, J. Lucas, R. P. Kapur, and A. M. Stevens, “LPS induces translocation of TLR4 in amniotic epithelium,” Placenta, vol. 28, no. 5-6, pp. 477–481, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Abe, H. Sinozaki, T. Takagi et al., “Identification of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible genes in human amniotic epithelial cells,” Reproductive Biology and Endocrinology, vol. 4, article no. 27, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J. R. Okita, N. Sagawa, M. L. Casey, and J. M. Snyder, “A comparison of human amnion tissue and amnion cells in primary culture by morphological and biochemical criteria,” In Vitro, vol. 19, no. 2, pp. 117–126, 1983. View at Google Scholar · View at Scopus
  21. K. Sun, R. Ma, X. Cui et al., “Glucocorticoids induce cytosolic phospholipase A2 and prostaglandin H synthase type 2 but not microsomal prostaglandin E synthase (PGES) and cytosolic PGES expression in cultured primary human amnion cells,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 11, pp. 5564–5571, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Li and J. R. G. Challis, “Corticotropin-releasing hormone and urocortin induce secretion of matrix metalloproteinase-9 (MMP-9) without change in tissue inhibitors of MMP-1 by cultured cells from human placenta and fetal membranes,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 12, pp. 6569–6574, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. W. Li, N. Alfaidy, and J. R. G. Challis, “Expression of extracellular matrix metalloproteinase inducer in human placenta and fetal membranes at term labor,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2897–2904, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Itoh, N. Sagawa, M. Hasegawa et al., “Brain natriuretic peptide is present in the human amniotic fluid and is secreted from amnion cells,” Journal of Clinical Endocrinology and Metabolism, vol. 76, no. 4, pp. 907–911, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Itoh, N. Sagawa, M. Hasegawa et al., “Transforming growth factor-β stimulates, and glucocorticoids and epidermal growth factor inhibit brain natriuretic peptide secretion from cultured human amnion cells,” Journal of Clinical Endocrinology and Metabolism, vol. 79, no. 1, pp. 176–182, 1994. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Guller, L. Kong, R. Wozniak, and C. J. Lockwood, “Reduction of extracellular matrix protein expression in human amnion epithelial cells by glucocorticoids: a potential role in preterm rupture of the fetal membranes,” Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 7, pp. 2244–2250, 1995. View at Google Scholar · View at Scopus
  27. Y. Ma, C. J. Lockwood, A. L. Bunim, D. A. Giussani, P. W. Nathanielsz, and S. Guller, “Cell type-specific regulation of fetal fibronectin expression in amnion: conservation of glucocorticoid responsiveness in human and nonhuman primates,” Biology of Reproduction, vol. 62, no. 6, pp. 1812–1817, 2000. View at Google Scholar · View at Scopus
  28. S. Takashima, H. Ise, P. Zhao, T. Akaike, and T. Nikaido, “Human amniotic epithelial cells possess hepatocyte-like characteristic and functions,” Cell Structure and Function, vol. 29, no. 3, pp. 73–84, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. S. V. Murphy, R. Lim, P. Heraud et al., “Human amnion epithelial cells induced to express functional cystic fibrosis transmembrane conductance regulator,” PLoS One, vol. 7, no. 9, Article ID e46533, 2012. View at Google Scholar
  30. R. Romero, P. Roslansky, E. Oyarzun et al., “Labor and infection: II. Bacterial endotoxin in amniotic fluid and its relationship to the onset of preterm labor,” American Journal of Obstetrics and Gynecology, vol. 158, no. 5, pp. 1044–1049, 1988. View at Google Scholar · View at Scopus
  31. J. A. Keelan, T. Sato, and M. D. Mitchell, “Interleukin (IL)-6 and IL-8 production by human amnion: regulation by cytokines, growth factors, glucocorticoids, phorbol esters, and bacterial lipopolysaccharide,” Biology of Reproduction, vol. 57, no. 6, pp. 1438–1444, 1997. View at Google Scholar · View at Scopus
  32. M. Lappas, M. Permezel, H. M. Georgiou, and G. E. Rice, “Regulation of phospholipase isozymes by nuclear factor-kappaB in human gestational tissues in vitro,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 5, pp. 2365–2372, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. M. D. Mitchell, M. C. Chang, T. Chaiworapongsa et al., “Identification of 9,11α-prostaglandin F2 in human amniotic fluid and characterization of its production by human gestational tissues,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 7, pp. 4244–4248, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Y. Kim, H. K. Shin, J. M. Choi, and K. W. Hong, “Inhibition of lipopolysaccharide-induced apoptosis by cilostazol in human umbilical vein endothelial cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 300, no. 2, pp. 709–715, 2002. View at Google Scholar
  35. J. A. Keelan, S. Khan, F. Yosaatmadja, and M. D. Mitchell, “Prevention of inflammatory activation of human gestational membranes in an ex vivo model using a pharmacological NF-κB inhibitor,” Journal of Immunology, vol. 183, no. 8, pp. 5270–5278, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Splichalova, I. Trebichavsky, Y. Muneta, Y. Mori, and I. Splichal, “Effect of bacterial virulence on IL-18 expression in the amnion infected with Escherichia coli,” American Journal of Reproductive Immunology, vol. 53, no. 5, pp. 255–260, 2005. View at Google Scholar
  37. S. J. Fortunato, R. Menon, and S. J. Lombardi, “Support for an infection-induced apoptotic pathway in human fetal membranes,” American Journal of Obstetrics and Gynecology, vol. 184, no. 7, pp. 1392–1398, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Suzuki, M. Kobayashi, K. Isatsu et al., “Mechanisms involved in apoptosis of human macrophages induced by lipopolysaccharide from Actinobacillus actinomycetemcomitans in the presence of cycloheximide,” Infection and Immunity, vol. 72, no. 4, pp. 1856–1865, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Karahashi, K. S. Michelsen, and M. Arditi, “Lipopolysaccharide-induced apoptosis in transformed bovine brain endothelial cells and human dermal microvessel endothelial cells: the role of JNK,” Journal of Immunology, vol. 182, no. 11, pp. 7280–7286, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Zhao, G. Cui, N. Zhang, Z. Liu, W. Sun, and Q. Peng, “Lipopolysaccharide induces endothelial cell apoptosis via activation of Na+/H+ exchanger 1 and calpain-dependent degradation of Bcl-2,” Biochemical and Biophysical Research Communications, vol. 427, no. 1, pp. 125–132, 2012. View at Google Scholar
  41. J. H. Fan, G. G. Feng, L. Huang et al., “Role of naofen in apoptosis of hepatocytes induced by lipopolysaccharide through mitochondrial signaling in rats,” Hepatology Research, vol. 42, no. 7, pp. 696–705, 2012. View at Google Scholar
  42. S. Kataoka, I. Furuta, H. Yamada et al., “Increased apoptosis of human fetal membranes in rupture of the membranes and chorioamnionitis,” Placenta, vol. 23, no. 2-3, pp. 224–231, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Parry and J. F. Strauss III, “Premature rupture of the fetal membranes,” The New England Journal of Medicine, vol. 338, no. 10, pp. 663–670, 1998. View at Publisher · View at Google Scholar · View at Scopus